Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 03/28/2025 at 14:00, 11 months 28 days ago

83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey
Jaguar Health's Canalevia-CA1 receives FDA approval for chemotherapy-induced diarrhea in dogs, addressing a critical unmet need in veterinary oncology

FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea Veterinary Oncology
BRIEF

published on 03/27/2025 at 13:35, 11 months 29 days ago

Jaguar Health Secures FDA Meeting to Discuss Crofelemer Results in Breast Cancer Trial

Crofelemer Jaguar Health Breast Cancer FDA Meeting OnTarget Study
BRIEF

published on 03/27/2025 at 13:35, 11 months 29 days ago

Jaguar Health obtient une réunion avec la FDA pour discuter des résultats de l'essai Crofelemer sur le cancer du sein

Crofelemer Jaguar Health Cancer Du Sein Réunion De La FDA Étude OnTarget
PRESS RELEASE

published on 03/27/2025 at 13:30, 11 months 29 days ago

Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study
Napo Pharmaceuticals presents statistically significant responder analysis results for crofelemer in breast cancer patients at San Antonio Breast Cancer Symposium and MASCC, FDA Type C Meeting scheduled for 2025

Napo Pharmaceuticals Crofelemer Breast Cancer FDA Meeting Responder Analysis
BRIEF

published on 03/26/2025 at 16:05, 11 months 30 days ago

Jaguar Health to Present at Emerging Growth Conference and Host Investor Webcast

Investor Webcast Jaguar Health Emerging Growth Conference Crofelemer Development Q4 2024 Financials
BRIEF

published on 03/26/2025 at 16:05, 11 months 30 days ago

Jaguar Health participera à la conférence Emerging Growth et organisera un webcast pour les investisseurs.

Jaguar Health Conférence Sur La Croissance Émergente Webcast Pour Les Investisseurs Développement Crofelemer Résultats Financiers Du Quatrième Trimestre 2024
PRESS RELEASE

published on 03/26/2025 at 16:00, 11 months 30 days ago

Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts
Jaguar Health, Inc. announces virtual presentation and investor webcast dates. Company to file annual report on March 31, 2025. Lisa Conte to discuss upcoming developments

Virtual Presentation Investor Webcast Annual Report Lisa Conte Jaguar Health Inc.
BRIEF

published on 03/26/2025 at 14:30, 11 months 30 days ago

Jaguar Health obtient un financement relais de 3,448 millions de dollars

Investissement Obligations Convertibles Jaguar Health Financement Relais Bons De Souscription D'actions
BRIEF

published on 03/26/2025 at 14:30, 11 months 30 days ago

Jaguar Health Secures $3.448 Million in Bridge Financing

Investment Bridge Financing Jaguar Health Convertible Notes Stock Warrants
PRESS RELEASE

published on 03/26/2025 at 14:25, 11 months 30 days ago

Jaguar Health CEO, Board Members, Other C-Suite Members, and Institutional and Accredited Investors Invest in $3.448 Million Bridge Financing Priced At-The-Market Under Nasdaq Rules
Jaguar Health, Inc. announced a private placement of convertible promissory notes to selected investors for working capital. H.C. Wainwright & Co. is the placement agent

Private Placement Working Capital Convertible Notes Jaguar Health Inc. H.C. Wainwright & Co.

Published on 03/25/2026 at 19:15, 2 hours 2 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 7 hours 47 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 7 hours 47 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 7 hours 47 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 7 hours 52 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets

View all ACCESSWIRE

Published on 03/25/2026 at 20:00, 1 hour 17 minutes ago

Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 1 hour 36 minutes ago

EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 1 hour 47 minutes ago

AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 1 hour 50 minutes ago

EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 2 hours 37 minutes ago

TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS

View all EQS

Published on 03/25/2026 at 18:53, 2 hours 23 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:53, 2 hours 24 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 2 hours 46 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 2 hours 46 minutes ago

Performance soutenue des Investissements et déploiement actif de la stratégie
Published on 03/25/2026 at 18:06, 3 hours 10 minutes ago

LNA SANTE : Résultats Annuels 2025

View all LES ECHOS COMFI WIRE

News